RecruitingNANCT06727877

Predictive Diagnosis of Ulcero-Necrotizing EnteroColitis in Premature Babies Using an Artificial Intelligence Approach Based on Early Analysis of the Fecal Microbiota

Sponsor: University Hospital, Clermont-Ferrand

Trial Details

ConditionNecrotizing Enterocolitis (NEC), Healthy Control
InterventionAbility of early digestive microbiota analysis (using artificial intelligence) to predict the occurrence of NEC diagnosed according to the Bell classification.
PhaseNA
StatusRecruiting
Participants1,000
Est. Completion1 June 2027
Last Updated6 Apr 2026

Primary Outcome

predictive diagnostic of NEC based on artificial intelligence analysis of fecal microbiota

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Child born prematurely (i.e. before 34 weeks of amenorrhea) in one of participating university hospitals and hospitalized in neonatal intensive care units of the AURA region's university hospitals * Child born outside CHU and transferred before 24h of life to the neonatal intensive care unit of one of thehospital participating in the study * Affiliated with a Social Security scheme Exclusion Criteria: * Child whose guardians are protected by law (guardianship, curatorship, safeguard of justice) * Children whose parents are under 18 years of age * Refusal of parental authority to participate

Trial Sites

Countries

France
View Registry Entry

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service